Orthocell

We’re pleased to introduce a new Q&A series spotlighting the senior leaders shaping Orthocell’s strategy, innovation and global growth. Each edition offers insight into the people driving our mission forward.

***

"Nerve injury is a quality-of-life story — when someone loses sensation or function, the consequences ripple through their entire life."

– Phil Edmondson, Orthocell's VP of US Commercialization

Phil Edmondson started his career in the US Army before spending close to two decades in medical devices. As Orthocell's VP of US Commercialization, he's now helping bring Remplir™ to a market that hasn't seen meaningful innovation in nearly a decade – and surgeon response has been positive.

In our first executive profile, Phil shares what drew him to this field, his perspective on the path from awareness to advocacy, and what the next 12 months look like for Remplir in the United States.

🔗 Take a look: https://bit.ly/OCC_Phil_Edmondson